Pharmaceutical Business review

Pfizer introduces Benefix in Europe

Benefix RTS can be stored for up to two years at room temperature (2-30°C) for about two years, thereby providing more convenience to haemophilia B patients, europeanpharmaceuticalreview reported.

Benefix is a recombinant factor IX (rFIX) product licensed for the treatment and prophylaxis of bleeding in patients with haemophilia B.

The product is said to be free from the risk of transmission of human blood-borne pathogens.

Pfizer regional resident Europe Cees Heiman said the treatment has transformed the outlook for haemophilia B patients over a decade ago.